DocGo Inc. (formerly Motion Acquisition Corp.) — Form 8-K Summary
Business context and reporting period
Motion Acquisition Corp. filed this current report in connection with its proposed business combination with Ambulnz, Inc. (“DocGo”). The stockholder meeting occurred on November 2, 2021. The filing was signed and includes an amended and restated Sponsor Agreement dated November 4, 2021, creating a date inconsistency that investors should verify.
Transaction, financial terms, and liquidity
- Motion stockholders approved the merger in which Motion Merger Sub would merge with and into DocGo, with DocGo surviving as a wholly owned subsidiary of Motion.
- DocGo agreed to waive the $175 million Minimum Cash Closing Condition, provided aggregate unpaid transaction expenses of Motion and DocGo related to the transaction did not exceed $29 million.
- The sponsor agreed to forfeit and defer certain shares of Motion Class A common stock based on the number of shares seeking redemption in connection with the business combination.
- The filing does not provide operating revenue, profit, cash flow, margin, debt, cash balance, redemption amount, or pro forma financial metrics.
Material changes and approvals
- All proposals submitted at the November 2 meeting were approved, including the business combination, charter amendments, director election, Nasdaq share issuance approval, and the 2021 Stock Incentive Plan.
- A total of 8,301,431 shares were represented at the meeting, constituting a quorum.
- The business combination proposal received 8,231,911 votes for, 69,250 against, and no abstentions or broker non-votes.
- Stockholders approved changing the company’s name from Motion Acquisition Corp. to DocGo Inc. following the merger.
- Approved charter amendments included replacing the two-class structure with one class of common stock, increasing authorized common shares from 50 million to 500 million, and increasing authorized preferred shares from 1 million to 50 million.
- Seven directors were elected to serve following the merger: Stan Vashovsky, Chris Fillo, Ely D. Tendler, Ira Smedra, Steven Katz, James M. Travers, and Michael Burdiek.
- The DocGo Inc. 2021 Stock Incentive Plan was approved with 7,494,547 votes for and 806,884 against.
Outlook, risks, contingencies, and unusual items
- Completion of the business combination remained subject to the applicable closing conditions, including the revised transaction-expense limitation and other requirements in the Merger Agreement.
- The waiver of the Minimum Cash Closing Condition increases the importance of final trust-account proceeds, redemptions, transaction expenses, and financing proceeds to the post-closing liquidity position.
- The filing does not provide management guidance, operating forecasts, or a post-merger financial outlook.
- The filing furnishes a press release under Regulation FD; the filing states that this information is not deemed filed under Section 18 of the Exchange Act unless specifically incorporated by reference.
Key facts investors should verify
- Whether and when the merger legally closed and when the name change to DocGo Inc. became effective.
- Final shareholder redemption levels, trust-account cash, transaction expenses, and compliance with the $29 million expense limitation.
- The number of shares issued to DocGo stockholders, sponsor forfeitures or deferrals, and resulting ownership dilution.
- The final capitalization, cash balance, debt, and liquidity profile of the combined company.
- The complete Amended and Restated Sponsor Agreement, because the filing’s summary is qualified by reference to the exhibit and contains an apparent exhibit-description inconsistency.